The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Interactions · continued

A widely repeated interaction claim that turns out to be unsupported — what changed since posts 61–90

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

JN
j.nwosuTL2 Moderator10 Jun 2026#61

Worth separating two things that post #57 runs together.

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

0 likes 2mo
BP
b.petrovTL2 Moderator11 Jun 2026#62

post #61 is right about the mechanism and I think understates the practical bit.

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

31 likes 2mo
NH
n.haddadTL2 Moderator13 Jun 2026#63
m.marchetti, post #39: Picking up post #36: that is the part I would want checked first. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

16 likes in reply to #39 1mo
NS
n.stanescuTL2 Moderator14 Jun 2026#64

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

6 likes 1mo
JM
j.mwangiTL4 Moderator16 Jun 2026#65
Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

0 likes 1mo
SC
s.coelhoTL2 Moderator17 Jun 2026#66
c.castellanos, post #56: Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management. Go to post

post #65 answers the question as asked. The question underneath it is different.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

23 likes in reply to #56 1mo
MS
m.strand_rphTL3Pharmacist19 Jun 2026 · edited#67

Coming back to post #65, because the follow-up matters more than the original answer.

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

10 likes 1mo
DE
d.eriksenTL2 Moderator20 Jun 2026#68

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

3 likes 1mo
YR
y.ramosTL2 Moderator22 Jun 2026#69

Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.

3 likes 1mo
ID
integrator_draftTL3Regular23 Jun 2026#70
y.asante, post #52: On post #48 — agreed on the reasoning, with one qualification. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination. Go to post

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

0 likes in reply to #52 1mo
FE
f.espinozaTL2 Moderator25 Jun 2026#71

This follows post #68 rather than contradicting it.

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

0 likes 1mo
W
WoodhouseTL2Member26 Jun 2026#72
BBramley, post #26: For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post

I read post #70 twice before replying, because I had assumed the opposite.

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

0 likes in reply to #26 1mo
SK
s.kravchenkoTL2 Moderator27 Jun 2026#73

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

4 likes 1mo
GF
gradient_fileTL2Member29 Jun 2026 · edited#74

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

12 likes 29d
ZA
z.adeyemiTL2 Moderator30 Jun 2026#75
orbitrap_ola, post #19: post #18 is right about the mechanism and I think understates the practical bit. Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well. Go to post

Picking up post #72: that is the part I would want checked first.

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

25 likes in reply to #19 28d
CN
cohort_notesTL2Member2 Jul 2026#76
e.almeida, post #36: Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches. Go to post

Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but that is a nutritional consequence rather than an interaction.

0 likes in reply to #36 26d
AK
an.kirchnerTL2 Moderator3 Jul 2026#77

Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you are on it; monitoring INR more frequently during weight loss is reasonable.

1 like 25d
R
RidgewayTL3Regular4 Jul 2026#78

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

7 likes 23d
AP
ar.petrovTL2 Moderator6 Jul 2026#79
j.habermann, post #28: This follows post #25 rather than contradicting it. Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion. Go to post

Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach.

0 likes in reply to #28 22d
FF
f.fenwickTL3Regular7 Jul 2026#80

Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as a clinically important interaction. Both can reduce absorption of one or the other, but only true interactions require active management.

3 likes 21d
AS
a.salcedoTL3Regular9 Jul 2026#81

Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted. That is a reason for close monitoring, not for avoiding the combination.

0 likes 19d
KH
ka.haddadTL2 Moderator10 Jul 2026#82

Picking up post #79: that is the part I would want checked first.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

32 likes 18d
J
JFitzgibbonTL2Member11 Jul 2026 · edited#83
n.stanescu, post #64: Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this. Go to post

Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or adjusting one if tolerability is poor are reasonable approaches.

11 likes in reply to #64 16d
SB
s.beaulieuTL2 Moderator13 Jul 2026#84
g.danquah, post #46: Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close together. Separating them by a few hours is the conservative approach. Go to post

Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist that already slows gastric emptying, food effects interact with the drug effect as well.

3 likes in reply to #46 15d
GH
g.haalandTL3Regular14 Jul 2026#85

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

0 likes 14d
TV
to.vargaTL2 Moderator16 Jul 2026#86

Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and where the oral medication is absorbed. Separating by a larger interval (1 to 2 hours) usually resolves this.

24 likes 12d
CD
cohort_driftTL3Regular17 Jul 2026#87

Worth separating two things that post #83 runs together.

Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration is to limit it.

7 likes 11d
IO
i.oseiTL2 Moderator18 Jul 2026#88
m.marchetti, post #39: Picking up post #36: that is the part I would want checked first. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern. Go to post

Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than guessing from forum discussion.

1 like in reply to #39 10d
FA
f.amankwahTL2 Moderator20 Jul 2026#89

Coming back to post #87, because the follow-up matters more than the original answer.

Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose adjustment of the secretagogue and close monitoring. The combination is not contraindicated but requires active management.

3 likes 8d
BO
b.okonkwoTL2 Moderator21 Jul 2026#90

SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.

0 likes 7d